Skip to main content
$268.13 -$2.70 (0.0%)

04:30 PM EDT on 04/25/19

ABIOMED, Inc. (NASDAQ:ABMD)

CAPS Rating: 5 out of 5

The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.

Current Price $268.13 Mkt Cap $11,820.60
Open $268.90 P/E Ratio 0.00
Prev. Close $268.13 Div. (Yield) $0.00 (0.0%)
Daily Range $265.00 - $277.95 Volume 216,911
52-Wk Range $244.08 - $364.07 Avg. Daily Vol. 12

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

326 Outperform
38 Underperform
 

All-Star Players

111 Outperform
13 Underperform
 

Wall Street

7 Outperform
4 Underperform
 

Top NASDAQ:ABMD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

gtechie (80.18)
Submitted September 21, 2015

Just tracking a curiosity...

Reply | Report this Post

ScreenerStizBear (40.06)
Submitted June 26, 2008

I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!

1 Reply | Report this Post
NASDAQ:ABMD VS S&P 500 (SPY)

Fools bullish on NASDAQ:ABMD are also bullish on:

Fools bearish on NASDAQ:ABMD are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ABMD.

Recs

0
Member Avatar keithelane (42.42) Submitted: 3/26/2019 7:37:19 PM : Outperform Start Price: $314.88 NASDAQ:ABMD Score: -18.77

No real competition, 30% growth, plenty of room to keep growing, perfect balance sheet, strong cash flow, what's not to like?

Report this Post Reply

Recs

0
Member Avatar wolfhounds (95.69) Submitted: 3/20/2019 10:57:28 AM : Outperform Start Price: $340.79 NASDAQ:ABMD Score: -25.03

Addressable population will only grow.

Report this Post Reply

Recs

0
Member Avatar MaestroFool (89.76) Submitted: 3/19/2019 9:10:34 PM : Outperform Start Price: $337.90 NASDAQ:ABMD Score: -24.19

Maker of the Impella RP heart pump, a market they've got cornered. I enjoyed learning about Abiomed and taking in Simon Erickson's enthusiasm for this company on the Industry Focus podcast (Feb 20, 2019): Healthcare | 3 Medical Device Monopolies. Outperform.

Report this Post Reply
View All 40 Pitches »

Leaderboard

Find the members with the highest scoring picks in ABMD.

Score Leader

ClaytonHP

ClaytonHP (< 20) Score: +4,587.29

The Score Leader is the player with the highest score across all their picks in ABMD.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
ClaytonHP < 20 3/27/2009 Outperform 3M $5.42 +4,847.05% +259.75% +4,587.29 0 Comment
NoWhereToGoButUp 79.98 3/25/2009 Outperform NS $5.44 +4,828.86% +270.46% +4,558.40 0 Comment
Dennyf10 62.47 6/3/2009 Outperform 1Y $6.44 +4,063.51% +217.38% +3,846.13 0 Comment
TSStechtrader 51.43 8/11/2009 Outperform NS $7.31 +3,567.99% +191.95% +3,376.04 0 Comment
dteasley4 87.12 6/8/2009 Outperform 3Y $7.30 +3,573.01% +214.56% +3,358.46 0 Comment
YahooSIRIous 85.76 7/13/2009 Outperform 5Y $7.93 +3,281.21% +232.40% +3,048.81 0 Comment
QuickStoch 96.86 7/15/2009 Outperform 3W $8.06 +3,226.67% +216.54% +3,010.14 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. henrik1123 45.68 1/8/2010 Outperform 5Y $8.21 +3,164.66% +155.86% +3,008.80 0 Comment
PitBullCapital 31.78 1/11/2010 Outperform 5Y $8.29 +3,134.38% +153.86% +2,980.52 0 Comment
ezdoggy 65.76 12/29/2009 Outperform 5Y $8.80 +2,946.93% +158.51% +2,788.42 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackJimCramer 86.08 1/27/2016 Underperform 3W $83.35 +221.69% +55.29% -166.41 0 Comment
TrackTheBenchmar 82.17 10/1/2013 Outperform NS $19.40 +1,282.11% +73.75% +1,208.37 0 Comment
TrackZacks < 20 11/2/2012 Underperform 3M $13.86 -2.24% -2.29% -0.05 11/12/2012 @ $13.55 1 Comment
TrackZacks < 20 7/11/2012 Outperform 3M $23.91 -6.61% +5.22% -11.83 8/31/2012 @ $22.33 1 Comment
TrackCitigroup 88.94 6/15/2012 Outperform NS $21.44 +1,150.61% +119.03% +1,031.58 0 Comment
TrackJimCramer 86.08 2/7/2012 Outperform 3W $22.70 +267.18% +39.57% +227.61 1/27/2016 @ $83.35 0 Comment
TrackRodmanRen < 20 12/19/2011 Underperform NS $18.36 +1,360.40% +139.34% -1,221.06 0 Comment
TrackZacks < 20 11/11/2011 Outperform 3M $19.41 +14.12% +5.91% +8.21 6/15/2012 @ $22.15 1 Comment
TrackRWBaird 87.82 4/29/2011 Outperform NS $17.16 +1,462.53% +114.56% +1,347.97 0 Comment
TrackWunderlich < 20 12/9/2010 Outperform NS $9.41 +2,749.42% +135.65% +2,613.76 0 Comment
TrackRodmanRen < 20 12/8/2010 Underperform NS $9.67 +26.78% -2.73% -29.52 8/15/2011 @ $12.26 0 Comment
TrackWedbush 86.04 5/11/2010 Outperform NS $9.20 +2,814.46% +153.88% +2,660.58 0 Comment
TrackUBS 91.35 10/31/2009 Underperform NS $9.19 +2,817.63% +174.83% -2,642.80 0 Comment
TrackPiperJaff 86.02 4/9/2009 Outperform NS $5.40 +204.07% +84.55% +119.52 4/9/2013 @ $16.42 0 Comment
TrackUBS 91.35 3/25/2009 Outperform NS $5.95 +54.45% +30.72% +23.74 10/30/2009 @ $9.19 0 Comment
TrackSMHCapital 31.62 7/29/2008 Underperform NS $18.80 +1,326.22% +140.81% -1,185.41 0 Comment
TrackLehmanBros < 20 12/20/2007 Outperform NS $15.00 +38.00% -5.97% +43.97 4/17/2012 @ $20.70 0 Comment
TrackUBS 91.35 12/7/2007 Outperform NS $13.67 -30.43% -43.26% +12.83 2/6/2009 @ $9.51 0 Comment
TrackStifel 90.47 11/9/2006 Outperform NS $13.55 +1,878.82% +123.03% +1,755.79 0 Comment
TrackLazardCapit 64.17 9/7/2006 Outperform NS $14.88 +1,701.95% +139.50% +1,562.45 0 Comment
TrackJimCramer 86.08 9/5/2006 Underperform 3W $14.98 +51.54% +2.31% -49.22 2/8/2012 @ $22.70 0 Comment

Advertisement